Pharmaceutical Price Regulation: Public Perception, Economic Realities, and Empirical Evidence (Paperback)
  • Pharmaceutical Price Regulation: Public Perception, Economic Realities, and Empirical Evidence (Paperback)
zoom

Pharmaceutical Price Regulation: Public Perception, Economic Realities, and Empirical Evidence (Paperback)

(author)
£9.49
Paperback 83 Pages / Published: 16/02/2009
  • Not available

This product is currently unavailable.

  • This item has been added to your basket
Breakthrough drugs have saved millions of lives and improved the health of countless people around the world. Unfortunately, they are also expensive, leading many political leaders to call for price controls, importation, or other procedures to reduce their cost. In Pharmaceutical Price Regulation: Public Perceptions, Economic Realities, and Empirical Evidence, John A. Vernon and Joseph H. Golec argue that price controls and other cost-limiting measures will starve pharmaceutical companies of the R&D money required to develop new drugs. A drug can cost $1 billion or more before it ever appears in the marketplaceand only three out of every ten new drugs ever recoup their development costs. This groundbreaking monograph demonstrates empirically how the free-market system of drug pricing is vital to the development of new breakthrough drugs. Drug companies take a long-term view towards R&D investment, balancing projected profits against the costs of clinical development. This puts them in conflict with politicians, who tend to focus on the short-term concerns of current voters. Prices set in the political arena will reflect current voters' wishes, as opposed to the full economic value of the pharmaceuticals. With less money to invest in R&D, drug companies would have no choice but to curtail product development that would serve the interests of future generations. While the United States has largely avoided the heavy-handed role of government price controls until now, Congress members and influential policymakers are setting the country on precisely this course. "Pharmaceutical price controls," Vernon and Golec argue, "constitute a short-sighted, wrong-headed, and possibly dangerous policy. The prices set by the free market are the signals absolutely necessary for corporations to decide whether to undertake expensive, risky research into new drugs."

Publisher: AEI Press
ISBN: 9780844742779
Number of pages: 83
Weight: 118 g
Dimensions: 217 x 142 x 7 mm

You may also be interested in...

Aromatherapy
Added to basket
£1.99
Paperback
The Fragrant Mind
Added to basket
Recovering with T3
Added to basket
£19.45
Paperback
Aromatherapy Lexicon
Added to basket
£4.99
Paperback
Oxford Handbook of Practical Drug Therapy
Added to basket
FASTtrack: Chemistry of Drugs
Added to basket
The Lost Language of Plants
Added to basket
Pass the PSA
Added to basket
£32.99
Paperback
The Myth of the Chemical Cure
Added to basket
The Inheritor's Powder
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.